Shilpa Medicare Limited (NSE:SHILPAMED)
India · Delayed Price · Currency is INR 949.30
+45.50 (5.03%)
Aug 31, 2026, 3:30 PM IST
Shilpa Medicare Market Cap
Shilpa Medicare has a market cap or net worth of 185.81 billion as of August 31, 2026. Its market cap has increased by 124.51% in one year.
Market Cap
185.81B
Enterprise Value
191.96B
Revenue
16.83B
Ranking
n/a
PE Ratio
62.49
Stock Price
949.30
ChartMarket Cap Chart
Since July 19, 1999, Shilpa Medicare's market cap has increased from 45.10M to 185.81B, an increase of 411,924.78%. That is a compound annual growth rate of 35.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 185.81B | 195.78% |
| Dec 31, 2025 | 62.82B | -11.35% |
| Dec 31, 2024 | 70.86B | 147.08% |
| Dec 29, 2023 | 28.68B | 18.74% |
| Dec 30, 2022 | 24.15B | -48.10% |
| Dec 31, 2021 | 46.54B | 26.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 354.59B |
| Wockhardt | 321.26B |
| Piramal Pharma | 290.22B |
| Eris Lifesciences | 182.19B |
| Cohance Lifesciences | 172.12B |
| Alivus Life Sciences | 165.72B |
| Alembic Pharmaceuticals | 164.11B |
| NATCO Pharma | 152.92B |